Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™
-- Training for physical therapists treating patients with multiple sclerosis (MS) is now available on demand --NEWTOWN, Pa., July 12,...
Day: July 12, 2022
Plus Therapeutics Successfully Completes Key Milestone for cGMP Manufacture of Lead Investigational Radiotherapeutic
Completes technology transfer and initiates cGMP manufacturing for critical Rhenium-186 NanoLiposome (186RNL) drug product intermediate On track to manufacture cGMP...
Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products
Societal to Receive Greater Portion of Profit Sharing from Verapamil PM Product Sales Societal Awarded Potential New GMP Manufacturing Agreements...
Rhythm Pharmaceuticals Announces Positive Interim Results from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity
--All evaluable patients (N=11) achieved BMI decrease of more than 5 percent at 16 weeks on setmelanotide therapy-- --17.2 percent...
Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCs
SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a...
Oncotelic Announces Presentation of P001- OT-101 Phase 1/2 Trial in Pancreatic Cancer
AGOURA HILLS, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments...
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation...
Catalyst Pharmaceuticals Announces Settlement of U.S. Patent Litigation and Resolution of Litigation Challenging Ruzurgi® Approval with Jacobus Pharmaceutical
As Part of the Settlement, Catalyst has Acquired Certain of Jacobus’ Intellectual Property Rights, Including the U.S. and Mexico Rights...
Philips spotlights latest AI-powered, software-defined MR smart systems at ECR 2022
Philips SmartSpeed MR software shot July 12, 2022 Philips SmartSpeed AI-based software receives FDA 510(k) clearance, delivering breakthrough high-speed, high-resolution...
Mainz Biomed Today to Provide Corporate Update for First Half of 2022
Company to Host Webcast Today - July 12th - at 4.00pm ETBERKELEY, Calif. and MAINZ, Germany, July 12, 2022 (GLOBE...
Sirona Biochem Corporate Update
VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) provides...
Vaccentis appoints Martin Munte as CEO and strengthens Board
Image of Vaccentis CEO Martin Munte, CEOMartin Munte has extensive leadership experience at Amgen, AstraZeneca and RocheStrengthening management after appointment...
LegoChem Biosciences and Glycotope Announce Research Collaboration and License Agreement for an Antibody for use as Antibody Drug Conjugate
Glycotope GlycotopeLegoChem Biosciences and Glycotope Announce Research Collaboration and License Agreement for an Antibody for use as Antibody Drug Conjugate...
Basilea announces Zevtera® (ceftobiprole) marketing authorization in Brazil
Basel/Allschwil, Switzerland, July 12, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today that its distribution partner...
Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and Management
NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025
Proceeds Support Advancement of Broad Pipeline of Novel Complement Product Candidates for Diseases of the Body, Brain and EyeBRISBANE, Calif.,...
Halberd Corporation Update, CEO Letter and 2022 Expectations
Q2 Accomplishments and a Look to the FutureJackson Center, Pennsylvania--(Newsfile Corp. - July 12, 2022) - Halberd Corporation (OTC Pink:...
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - July 12, 2022) - Emerald Health Therapeutics, Inc. ("Emerald" or the "Company") (CSE: EMH) (OTCQB:...
Sage Dental and SheepMedical to Launch KiyoClear Orthodontic Aligners in the United States
KiyoClear’s Patented Aligner-Expander Technology Will Be Available in Sage Dental’s 80-Plus Practices in Fall 2022 BOCA RATON, Fla.--(BUSINESS WIRE)--Sage Dental,...
Story Health Appoints Cardiovascular Changemaker Andrew Sauer, MD to Advisory Board
Renowned Cardiologist and Innovator Brings Unparalleled Expertise to Story Health and Fuels Mission of Transforming Care for Americans with Heart...